GILTERITINIB for Acute myeloid leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,963 adverse event reports in the FDA FAERS database where GILTERITINIB was used for Acute myeloid leukaemia.
Most Reported Side Effects for GILTERITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Acute myeloid leukaemia | 366 | 10.0% | 247 | 120 |
| Febrile neutropenia | 346 | 9.4% | 115 | 235 |
| Off label use | 334 | 9.1% | 79 | 104 |
| Platelet count decreased | 327 | 8.9% | 61 | 139 |
| Pneumonia | 302 | 8.2% | 133 | 192 |
| Myelosuppression | 300 | 8.2% | 75 | 114 |
| Pyrexia | 281 | 7.7% | 84 | 193 |
| Death | 206 | 5.6% | 206 | 52 |
| Product use issue | 189 | 5.2% | 55 | 50 |
| Hepatic function abnormal | 181 | 4.9% | 61 | 93 |
| Neutrophil count decreased | 162 | 4.4% | 35 | 60 |
| Acute myeloid leukaemia recurrent | 155 | 4.2% | 39 | 44 |
| Anaemia | 154 | 4.2% | 37 | 75 |
| Infection | 153 | 4.2% | 76 | 89 |
| Cytopenia | 152 | 4.1% | 32 | 36 |
Other Indications for GILTERITINIB
Acute myeloid leukaemia recurrent (669)
Acute myeloid leukaemia refractory (548)
Product used for unknown indication (511)
Flt3 gene mutation (210)
Acute myeloid leukaemia (in remission) (21)
Acute monocytic leukaemia (20)
Acute leukaemia (19)
Leukaemia (17)
Acute myelomonocytic leukaemia (16)
Chronic myelomonocytic leukaemia (15)
Other Drugs Used for Acute myeloid leukaemia
VENETOCLAX (19,774)
AZACITIDINE (9,065)
CYTARABINE (8,295)
IDARUBICIN (2,427)
DAUNORUBICIN (2,423)
ENASIDENIB (2,220)
FLUDARABINE (1,927)
MIDOSTAURIN (1,653)
DECITABINE (1,400)
ETOPOSIDE (1,374)